S100A14 and neoplasm: Analyses of lung ADC cases have shown frequent upregulation of S100A14 in tumor tissues and serum correlating strongly with poor differentiation, metastasis, advanced disease stage, smoking history, EGFR mutations, and unfavorable patient outcomes (148, 149).